Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done? - PubMed
Review
Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?
Chris Kenyon et al. Curr Opin Infect Dis. 2020 Feb.
Abstract
Purpose of review: The combined incidence of chlamydia, gonorrhoea and syphilis in MSM PrEP (preexposure prophylaxis) cohorts now frequently exceeds 100 per 100 person years. The efficacy of antiretroviral PrEP in reducing HIV transmission has led to efforts to find similar biomedical ways reduce sexually transmitted infection (STI) incidence. We review the recent evidence for these and other strategies.
Recent findings: Doxycycline PrEP/postexposure prophylaxis has been shown to reduce the incidence of syphilis and chlamydia but not gonorrhoea. A meningococcal vaccine has been found to result in a lower incidence of gonorrhoea. Novel insights into the role of the pharynx in the transmission of gonorrhoea have led to clinical trials of oral antiseptics to reduce the spread of gonorrhoea. Intensified STI screening has been introduced in a number of clinics. Serious concerns have however been raised about the emergence of resistance to each of these strategies. This is particularly true for doxycycline PrEP which is not advocated by any guidelines we reviewed.
Summary: Randomized controlled trials are urgently required to ascertain the benefits and risks of interventions to reduce STIs in MSM PrEP cohorts.
Similar articles
-
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, Malinski C, Perkins R, Nasser M, Lopez C, Vittinghoff E, Buchbinder SP, Scott H, Charlebois ED, Havlir DV, Soge OO, Celum C; DoxyPEP Study Team. Luetkemeyer AF, et al. N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934. N Engl J Med. 2023. PMID: 37018493 Free PMC article. Clinical Trial.
-
Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. Hoornenborg E, et al. Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6. Lancet HIV. 2019. PMID: 31178284
-
Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS) Study Group. Traeger MW, et al. Lancet Infect Dis. 2022 Aug;22(8):1231-1241. doi: 10.1016/S1473-3099(22)00175-X. Epub 2022 May 25. Lancet Infect Dis. 2022. PMID: 35643090
-
Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, Rafael S, Falconer J, Terris-Prestholt F, Mameletzis I, Mayaud P. Ong JJ, et al. J Int AIDS Soc. 2021 Feb;24(2):e25673. doi: 10.1002/jia2.25673. J Int AIDS Soc. 2021. PMID: 33605081 Free PMC article. Review.
-
Sangani P, Rutherford G, Wilkinson D. Sangani P, et al. Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. PMID: 15106156 Updated. Review.
Cited by
-
Akomoneh EA, Laumen JGE, Abdellati S, Van Dijck C, Vanbaelen T, Britto XB, Manoharan-Basil SS, Kenyon C. Akomoneh EA, et al. Microorganisms. 2022 Dec 16;10(12):2497. doi: 10.3390/microorganisms10122497. Microorganisms. 2022. PMID: 36557750 Free PMC article.
-
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity.
Stewart J, Baeten JM. Stewart J, et al. Nat Rev Urol. 2022 Jan;19(1):7-15. doi: 10.1038/s41585-021-00527-4. Epub 2021 Oct 25. Nat Rev Urol. 2022. PMID: 34697493 Free PMC article. Review.
-
Kenyon C. Kenyon C. Pathogens. 2020 Feb 18;9(2):134. doi: 10.3390/pathogens9020134. Pathogens. 2020. PMID: 32085650 Free PMC article. Review.
-
Baltes V, de Boissieu P, Champenois K, Luan L, Seng R, Essat A, Novelli S, Spire B, Molina JM, Goujard C, Meyer L; ANRS PRIMO cohort study group. Baltes V, et al. J Int AIDS Soc. 2024 Mar;27(3):e26226. doi: 10.1002/jia2.26226. J Int AIDS Soc. 2024. PMID: 38462760 Free PMC article.
-
In Vitro Susceptibility of Treponema pallidum subsp. pallidum to Doxycycline.
Edmondson DG, Wormser GP, Norris SJ. Edmondson DG, et al. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00979-20. doi: 10.1128/AAC.00979-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32718967 Free PMC article.
References
-
- Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis 2017; 17:e235–e279.
-
- Mohammed H, Mitchell H, Sile B, et al. Increase in sexually transmitted infections among men who have sex with men, England, 2014. Emerg Infect Dis 2016; 22:88–91.
-
- Centre for Disease Control and Prevention, CDC. New CDC analysis shows steep and sustained increases in STDs in recent years. 2018; Available at: https://wwwcdcgov/media/releases/2018/p0828-increases-in-stdshtml. Accessed 21 August 2019.
-
- Public Health England. Inequalities in sexual health: update on HIV and STIs in men who have sex with men in London. London: Public Health England; 2016.
-
- Public Health England, Public Health England. Sexually transmitted infections and screening for chlamydia in England, 2017. Health Protection Report 2018; 12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous